Published in Hematology Week, July 28th, 2008
"Thousands of patients will benefit and live longer if the government and private payers adequately reimburse highly effective radioimmunotherapies," said...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.